Literature DB >> 8685357

Selective percutaneous transhepatic embolization of the portal vein in preparation for extensive liver resection: the ipsilateral approach.

M Nagino1, Y Nimura, J Kamiya, S Kondo, M Kanai.   

Abstract

The ipsilateral approach was used at preoperative portal vein embolization in 38 patients with hepatobiliary malignancy. The right anterior portal branch was punctured. Two different 5.5-F triple-lumen balloon catheters were used, and fibrin glue and iodized oil were injected. Portal vein embolization was successful in all cases (right lobe, 24 patients; left lobe and right anterior segment, six; right lobe and left medial segment, three; right posterior segment, two; right anterior segment, one; left lobe, one; and right and caudate lobes, one).

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8685357     DOI： 10.1148/radiology.200.2.8685357

Source DB:  PubMed          Journal:  Radiology        ISSN： 0033-8419            Impact factor:   11.105


  41 in total

1.  Changes in splenic volume during liver regeneration.

Authors:  Hideya Ando; Masato Nagino; Toshiyuki Arai; Hideki Nishio; Yuji Nimura
Journal:  World J Surg       Date:  2004-09-29       Impact factor: 3.352

2.  "Anatomic" right hepatic trisectionectomy (extended right hepatectomy) with caudate lobectomy for hilar cholangiocarcinoma.

Authors:  Masato Nagino; Junichi Kamiya; Toshiyuki Arai; Hideki Nishio; Tomoki Ebata; Yuji Nimura
Journal:  Ann Surg       Date:  2006-01       Impact factor: 12.969

Review 3.  Treatment for multiple bilobar liver metastases of colorectal cancer.

Authors:  Hiroshi Shimada; Kuniya Tanaka; Kenichi Matsuo; Shinji Togo
Journal:  Langenbecks Arch Surg       Date:  2005-12-01       Impact factor: 3.445

4.  Percutaneous ipsilateral portal vein embolization using a modified four-lumen balloon catheter with fibrin glue: initial clinical experience.

Authors:  Masaki Gibo; Shinobu Unten; Akira Yogi; Tadashi Nakayama; Yuichirou Ayukawa; Shinji Gibo; Sadayuki Murayama; Makoto Takara; Masayuki Shiraishi
Journal:  Radiat Med       Date:  2007-05-28

5.  Hepatic outflow occlusion in laparoscopic hepatectomy.

Authors:  J F Zhu; R Nahouraii; F Rubino; V N Pamoukian; M Gagner
Journal:  HPB (Oxford)       Date:  2001       Impact factor: 3.647

6.  The Predictive Value of Indocyanine Green Clearance in Future Liver Remnant for Posthepatectomy Liver Failure Following Hepatectomy with Extrahepatic Bile Duct Resection.

Authors:  Yukihiro Yokoyama; Tomoki Ebata; Tsuyoshi Igami; Gen Sugawara; Takashi Mizuno; Junpei Yamaguchi; Masato Nagino
Journal:  World J Surg       Date:  2016-06       Impact factor: 3.352

7.  A left hepatectomy and caudate lobectomy combined resection of the ventral segment of the right anterior sector for hilar cholangiocarcinoma--the efficacy of PVE (portal vein embolization) in identifying the hepatic subsegment: report of a case.

Authors:  Tsuyoshi Igami; Yukihiro Yokoyama; Hideki Nishio; Tomoki Ebata; Gen Sugawara; Yoshiki Senda; Koji Oda; Tetsuya Abe; Keisuke Uehara; Masato Nagino
Journal:  Surg Today       Date:  2009-06-28       Impact factor: 2.549

8.  En bloc resection of the hepatoduodenal ligament for advanced biliary malignancy.

Authors:  Yuji Kaneoka; Atsuyuki Maeda; Masatoshi Isogai
Journal:  J Gastrointest Surg       Date:  2015-01-06       Impact factor: 3.452

9.  Six-year survival following left hepatic trisectionectomy with simultaneous resection of the portal vein and right hepatic artery for advanced perihilar cholangiocarcinoma without lymph node metastases: report of a case.

Authors:  Takashi Seki; Tsuyoshi Igami; Tomoki Ebata; Yukihiro Yokoyama; Gen Sugawara; Kiyoshi Suzumura; Masato Nagino
Journal:  Clin J Gastroenterol       Date:  2012-07-25

10.  Value of Multidetector-row Computed Tomography in Diagnosis of Portal Vein Invasion by Perihilar Cholangiocarcinoma.

Authors:  Teiichi Sugiura; Hideki Nishio; Masato Nagino; Yoshiki Senda; Tomoki Ebata; Yukihiro Yokoyama; Tsuyoshi Igami; Koji Oda; Yuji Nimura
Journal:  World J Surg       Date:  2008-07       Impact factor: 3.352
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.